• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习算法在细胞学标本中区分大细胞神经内分泌癌与小细胞肺癌的可行性。

Feasibility of a deep learning algorithm to distinguish large cell neuroendocrine from small cell lung carcinoma in cytology specimens.

机构信息

Department of Pathology and Laboratory Medicine, University of Miami Health System, Miami, FL, USA.

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

出版信息

Cytopathology. 2020 Sep;31(5):426-431. doi: 10.1111/cyt.12829. Epub 2020 May 20.

DOI:10.1111/cyt.12829
PMID:32246504
Abstract

INTRODUCTION

Distinguishing small cell lung carcinoma (SCLC) from large cell neuroendocrine carcinoma (LCNEC) in cytology is challenging. Our aim was to design a deep learning algorithm for classifying high-grade neuroendocrine carcinomas in fine needle aspirations.

METHODS

Archival cytology cases of high-grade neuroendocrine carcinoma (17 small cell, 13 large cell, 10 mixed/unclassifiable) were retrieved. Each case included smears (Diff-Quik® and Papanicolaou stains) and cell block or concomitant core biopsies (haematoxylin and eosin [H&E] stain). All slides (n = 114) were scanned at 40× magnification, randomised and split into training (11 large, nine small) and test (two large, eight small, 10 mixed) groups. Tumour was annotated using QuPath and exported as JPEG image tiles. Three distinct deep learning convolutional neural networks, one for each preparation/stain, were designed to classify each tile and provide an overall diagnosis for each slide.

RESULTS

The H&E-trained algorithm correctly classified 7/8 (87.5%) SCLC cases and 2/2 (100%) LCNEC cases. The Papanicolaou stain algorithm correctly classified 6/7 (85.7%) SCLC. and 1/1 (100%) LCNEC cases. The algorithm trained on Diff-Quik® stained images correctly classified 7/8 (87.5%) SCLC and 1/1 (100%) LCNEC cases.

CONCLUSION

Using open source software, it was feasible to design a deep learning algorithm to distinguish between SCLC and LCNEC. The algorithm showed high precision in distinguishing between these two categories on H&E sectioned material and direct smears. Although the dataset was limited, our deep learning models show promising results in the classification of LCNEC and SCLC. Additional work using a larger dataset is necessary to improve the algorithm's performance.

摘要

简介

在细胞学中区分小细胞肺癌(SCLC)和大细胞神经内分泌癌(LCNEC)具有挑战性。我们的目的是设计一种深度学习算法,用于分类细针抽吸的高级神经内分泌癌。

方法

回顾性检索高级神经内分泌癌(17 例小细胞、13 例大细胞、10 例混合/无法分类)的存档细胞学病例。每个病例包括涂片(Diff-Quik®和巴氏染色)和细胞块或伴随的核心活检(苏木精和伊红[H&E]染色)。所有载玻片(n=114)均以 40×放大倍数扫描,随机分为训练组(11 例大细胞,9 例小细胞)和测试组(2 例大细胞,8 例小细胞,10 例混合)。使用 QuPath 对肿瘤进行注释,并以 JPEG 图像块的形式导出。设计了三个不同的深度学习卷积神经网络,分别用于每种制备/染色,以对每个图像块进行分类,并为每个载玻片提供总体诊断。

结果

H&E 训练的算法正确分类了 8/8(87.5%)例 SCLC 病例和 2/2(100%)例 LCNEC 病例。巴氏染色算法正确分类了 6/7(85.7%)例 SCLC 病例和 1/1(100%)例 LCNEC 病例。在 Diff-Quik®染色图像上训练的算法正确分类了 8/8(87.5%)例 SCLC 病例和 1/1(100%)例 LCNEC 病例。

结论

使用开源软件,设计一种深度学习算法来区分 SCLC 和 LCNEC 是可行的。该算法在 H&E 切片和直接涂片上对这两种类型的区分具有很高的准确性。尽管数据集有限,但我们的深度学习模型在 LCNEC 和 SCLC 的分类中显示出有希望的结果。需要使用更大的数据集来改进算法的性能。

相似文献

1
Feasibility of a deep learning algorithm to distinguish large cell neuroendocrine from small cell lung carcinoma in cytology specimens.深度学习算法在细胞学标本中区分大细胞神经内分泌癌与小细胞肺癌的可行性。
Cytopathology. 2020 Sep;31(5):426-431. doi: 10.1111/cyt.12829. Epub 2020 May 20.
2
Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis.肺大细胞神经内分泌癌:细胞学诊断的推荐标准
Diagn Cytopathol. 2001 Jan;24(1):58-64. doi: 10.1002/1097-0339(200101)24:1<58::aid-dc1010>3.0.co;2-o.
3
The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens.锌指 E 盒结合蛋白 1(ZEB1)转录因子在细胞学和手术标本中用于诊断肺肉瘤样癌的应用。
J Am Soc Cytopathol. 2020 Jan-Feb;9(1):55-61. doi: 10.1016/j.jasc.2019.09.003. Epub 2019 Sep 27.
4
Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.比较四种 DLL3 抗体在高级别神经内分泌肺肿瘤样本和细胞培养物中的性能。
Diagn Pathol. 2019 May 20;14(1):47. doi: 10.1186/s13000-019-0827-z.
5
A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.肺外周、小细胞型高级神经内分泌肿瘤的临床病理研究:小细胞肺癌与大细胞神经内分泌癌的区别。
Eur J Cardiothorac Surg. 2012 Apr;41(4):841-6. doi: 10.1093/ejcts/ezr132. Epub 2011 Dec 21.
6
Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.肺小细胞癌与大细胞神经内分泌癌的观察者间变异性。
Histopathology. 2010 Feb;56(3):356-63. doi: 10.1111/j.1365-2559.2010.03486.x.
7
Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.大细胞神经内分泌癌、小细胞肺癌和大细胞癌的基因组图谱比较。
Thorac Cancer. 2019 Apr;10(4):839-847. doi: 10.1111/1759-7714.13011. Epub 2019 Feb 21.
8
Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.用于肺大细胞神经内分泌癌诊断明确的真实世界综合基因组分析数据。
Lung Cancer. 2024 Feb;188:107454. doi: 10.1016/j.lungcan.2023.107454. Epub 2023 Dec 29.
9
Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma.Rb1、cyclin D1 和 p16 免疫组化表达的比较研究,以区分肺小细胞癌和大细胞神经内分泌癌。
Histopathology. 2022 Aug;81(2):205-214. doi: 10.1111/his.14679. Epub 2022 May 27.
10
Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.经支气管超声引导经支气管针吸术对肺大细胞神经内分泌癌的病理诊断。
Thorac Cancer. 2018 Feb;9(2):273-277. doi: 10.1111/1759-7714.12576. Epub 2017 Dec 22.

引用本文的文献

1
Clinical needs and pathology's answers in neuroendocrine neoplasms of the lung.肺部神经内分泌肿瘤的临床需求与病理学解答
Pathologica. 2025 Jun;117(3):220-242. doi: 10.32074/1591-951X-N1102. Epub 2025 Jun 27.
2
Challenges and Opportunities in Cytopathology Artificial Intelligence.细胞病理学人工智能中的挑战与机遇
Bioengineering (Basel). 2025 Feb 13;12(2):176. doi: 10.3390/bioengineering12020176.
3
Automated recognition and segmentation of lung cancer cytological images based on deep learning.基于深度学习的肺癌细胞学图像自动识别与分割
PLoS One. 2025 Jan 31;20(1):e0317996. doi: 10.1371/journal.pone.0317996. eCollection 2025.
4
Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC.DLL3、ASC1、TTF-1 和 Ki-67 的表达关系:小细胞肺癌精准医学的初探。
Oncotarget. 2024 Oct 11;15:750-763. doi: 10.18632/oncotarget.28660.
5
Advances in artificial intelligence applications in the field of lung cancer.人工智能在肺癌领域的应用进展。
Front Oncol. 2024 Sep 6;14:1449068. doi: 10.3389/fonc.2024.1449068. eCollection 2024.
6
Deep learning-based diagnosis of lung cancer using a nationwide respiratory cytology image set: improving accuracy and inter-observer variability.使用全国范围的呼吸细胞学图像集基于深度学习的肺癌诊断:提高准确性和观察者间的变异性。
Am J Cancer Res. 2023 Nov 15;13(11):5493-5503. eCollection 2023.
7
Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review.使用组织学和细胞学图像的深度学习在肺癌诊断、预后和预测中的应用:一项系统综述。
Cancers (Basel). 2023 Aug 5;15(15):3981. doi: 10.3390/cancers15153981.
8
Deep Learning-Based Computational Cytopathologic Diagnosis of Metastatic Breast Carcinoma in Pleural Fluid.基于深度学习的胸腔积液转移性乳腺癌的计算细胞病理学诊断。
Cells. 2023 Jul 13;12(14):1847. doi: 10.3390/cells12141847.
9
Recent Application of Artificial Intelligence in Non-Gynecological Cancer Cytopathology: A Systematic Review.人工智能在非妇科癌症细胞病理学中的最新应用:一项系统综述
Cancers (Basel). 2022 Jul 20;14(14):3529. doi: 10.3390/cancers14143529.
10
The state of the art for artificial intelligence in lung digital pathology.人工智能在肺部数字病理学中的最新进展。
J Pathol. 2022 Jul;257(4):413-429. doi: 10.1002/path.5966. Epub 2022 Jun 20.